Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989408883> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W1989408883 abstract "In an effort to search for new, synergistic and non-cross-resistant antileukemic regimens, the Cancer and Leukemia Group B (CALGB) investigated the activity and toxicity of mitoxantrone in combination with etoposide for the reinduction of patients with relapsed or refractory acute myelocytic leukemia (AML). Mitoxantrone, 12 mg/m2 daily for 3 days, was combined with three dose levels of etoposide, 100, 150 and 200 mg/m2 daily by constant infusion for 5 days. There were 19 male and 13 female patients, with a median age of 46 (range, 21-74). Of these, nine were primarily refractory to daunorubicin and ara-C; 17 had one prior complete remission (CR), five had two prior CR, and one had three prior CR. Thirteen patients were entered at the first dose level, 11 were entered at the second, and eight at the third. All but one patient, whose death occurred within the first 2 days of treatment, are evaluable for toxicity. There were five CR (four at the first and one at the second dose level) and six partial remissions (PR) (three at the first dose level and three at the second). Unmaintained responses lasted 6-33 weeks. Median survival for all patients was 12.6 weeks. Anti-leukemic effects with severe marrow hypoplasia were observed in all patients; severe nausea and vomiting were seen in four. Severe mucositis, often indistinguishable from superimposed candidiasis, occurred in 40% of all patients; it was associated with dose-limiting esophagitis (three of seven evaluable patients) at the highest etoposide dose. Hepatic and renal dysfunction was severe in three patients; no treatment-related severe pulmonary or cardiac toxicity was observed. Posttreatment infectious complications were severe in 11 patients. In three cases, they were fatal--an incidence not dissimilar from that of other reinduction regimens in heavily pretreated patients. The regimen appears to be active; the combination of mitoxantrone, 12 mg/m2 daily for 3 days, with etoposide, 150 mg/m2/day for 5 days, by constant intravenous infusion is now being explored by the CALGB in a randomized phase II study against mitoxantrone plus diazoquinone and diazoquinone plus etoposide." @default.
- W1989408883 created "2016-06-24" @default.
- W1989408883 creator A5001230244 @default.
- W1989408883 creator A5021092277 @default.
- W1989408883 creator A5046213358 @default.
- W1989408883 creator A5053028635 @default.
- W1989408883 creator A5072965952 @default.
- W1989408883 date "1990-12-01" @default.
- W1989408883 modified "2023-10-17" @default.
- W1989408883 title "Mitoxantrone and Constant Infusion Etoposide for Relapsed and Refractory Acute Myelocytic Leukemia" @default.
- W1989408883 doi "https://doi.org/10.1097/00000421-199012000-00013" @default.
- W1989408883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2239806" @default.
- W1989408883 hasPublicationYear "1990" @default.
- W1989408883 type Work @default.
- W1989408883 sameAs 1989408883 @default.
- W1989408883 citedByCount "19" @default.
- W1989408883 countsByYear W19894088832012 @default.
- W1989408883 countsByYear W19894088832013 @default.
- W1989408883 countsByYear W19894088832016 @default.
- W1989408883 countsByYear W19894088832018 @default.
- W1989408883 crossrefType "journal-article" @default.
- W1989408883 hasAuthorship W1989408883A5001230244 @default.
- W1989408883 hasAuthorship W1989408883A5021092277 @default.
- W1989408883 hasAuthorship W1989408883A5046213358 @default.
- W1989408883 hasAuthorship W1989408883A5053028635 @default.
- W1989408883 hasAuthorship W1989408883A5072965952 @default.
- W1989408883 hasConcept C121332964 @default.
- W1989408883 hasConcept C126322002 @default.
- W1989408883 hasConcept C141071460 @default.
- W1989408883 hasConcept C142424586 @default.
- W1989408883 hasConcept C2776694085 @default.
- W1989408883 hasConcept C2778119113 @default.
- W1989408883 hasConcept C2778461978 @default.
- W1989408883 hasConcept C2778496288 @default.
- W1989408883 hasConcept C2780580376 @default.
- W1989408883 hasConcept C2780852908 @default.
- W1989408883 hasConcept C2780923524 @default.
- W1989408883 hasConcept C29730261 @default.
- W1989408883 hasConcept C71924100 @default.
- W1989408883 hasConcept C87355193 @default.
- W1989408883 hasConcept C90924648 @default.
- W1989408883 hasConceptScore W1989408883C121332964 @default.
- W1989408883 hasConceptScore W1989408883C126322002 @default.
- W1989408883 hasConceptScore W1989408883C141071460 @default.
- W1989408883 hasConceptScore W1989408883C142424586 @default.
- W1989408883 hasConceptScore W1989408883C2776694085 @default.
- W1989408883 hasConceptScore W1989408883C2778119113 @default.
- W1989408883 hasConceptScore W1989408883C2778461978 @default.
- W1989408883 hasConceptScore W1989408883C2778496288 @default.
- W1989408883 hasConceptScore W1989408883C2780580376 @default.
- W1989408883 hasConceptScore W1989408883C2780852908 @default.
- W1989408883 hasConceptScore W1989408883C2780923524 @default.
- W1989408883 hasConceptScore W1989408883C29730261 @default.
- W1989408883 hasConceptScore W1989408883C71924100 @default.
- W1989408883 hasConceptScore W1989408883C87355193 @default.
- W1989408883 hasConceptScore W1989408883C90924648 @default.
- W1989408883 hasLocation W19894088831 @default.
- W1989408883 hasLocation W19894088832 @default.
- W1989408883 hasOpenAccess W1989408883 @default.
- W1989408883 hasPrimaryLocation W19894088831 @default.
- W1989408883 hasRelatedWork W1958319993 @default.
- W1989408883 hasRelatedWork W1976396371 @default.
- W1989408883 hasRelatedWork W1980701009 @default.
- W1989408883 hasRelatedWork W2006876985 @default.
- W1989408883 hasRelatedWork W2076411732 @default.
- W1989408883 hasRelatedWork W2362862715 @default.
- W1989408883 hasRelatedWork W2399102665 @default.
- W1989408883 hasRelatedWork W2415576058 @default.
- W1989408883 hasRelatedWork W3025665411 @default.
- W1989408883 hasRelatedWork W3032130105 @default.
- W1989408883 isParatext "false" @default.
- W1989408883 isRetracted "false" @default.
- W1989408883 magId "1989408883" @default.
- W1989408883 workType "article" @default.